Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Thrombosis 1Lymphoma, Follicular 1Ischemic Stroke 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Clopidogrel × Clear all
NCT03245489 2025-01-31

Anti-platelet + Pembro for H&N Tumors

Medical University of South Carolina

Phase 1 Completed
20 enrolled
Head & Neck

Head and Neck Neoplasms

NCT05507645 2024-09-05

PUMICE

Beijing Tiantan Hospital

Phase 3 Completed
1,446 enrolled
Lymphoid

Ischemic Stroke, Lymphoma, Follicular, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡